HEALTH● LOWAug 26 · Aug 26, 2026, 1:45 AM
Caliway CBL - 514 Combination Therapy Cleared by U . S . FDA for Phase 2 Trial ; Pivotal Phase 3 Trial SUPREME - 01 Initiates Enrollment
prnewswire.com · United States
Caliway's CBL-514 combination therapy has been cleared by the U.S. FDA for a Phase 2 trial, and its pivotal Phase 3 trial, SUPREME-01, has begun enrollment. This marks significant progress in the development of a new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH50m agoGoulburn Out of Shadows Walk remembers lives lost to suicide | Goulburn Postgoulburnpost.com.au · AustraliaHEALTH1h agoSuicide Awareness Month : The Importance of Communitythegeorgeanne.com · United StatesHEALTH3h agoJapan goes on student suicide watch as school term startsSouth China Morning PostHEALTH3h agoToo Young To Be Sick Like Thisktep.org · United States